Less than two years af­ter nine-fig­ure IPO, Ap­plied Mol­e­c­u­lar Trans­port cuts back on staff, pipeline ef­forts

Another day, another biotech undergoing a significant shift thanks to the bear market. Wednesday’s victim is Applied Molecular Transport. This morning the San Francisco-based biotech said it would lay …
( read original story …)